Rasha Abu El-Ruz , Ovelia A. Masoud , Amal A. Ibrahim , Tawanda Chivese , Susu M. Zughaier
{"title":"卡塔尔耐药细菌感染的流行病学:系统回顾和荟萃分析","authors":"Rasha Abu El-Ruz , Ovelia A. Masoud , Amal A. Ibrahim , Tawanda Chivese , Susu M. Zughaier","doi":"10.1016/j.jiph.2025.102732","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Antimicrobial resistance (AMR) is the current silent pandemic responsible for approximately five million deaths annually. According to the WHO, antimicrobial resistance is one of the top global public health threats and the third leading cause of death worldwide.</div></div><div><h3>Method</h3><div>This systematic review and meta-analyses aims to provide Qatar's first comprehensive epidemiological assessment of AMR. We conducted extensive search of three databases (PubMed, Embase and Web of Science) using broad search terms with no restrictions. The meta-analysis of prevalence was done using the Freeman-Turkey transformation and random effects models. Subgroup analysis was performed for three categories; the composite isolates, otherwise responsive isolates, and otherwise resistant isolates.</div></div><div><h3>Results</h3><div>The search yielded a total of 1258 publications, of which 55 publications were included. The overall prevalence of all isolates was <strong>13.64 %</strong> (95 %CI: 6.80 – 22.11, I<sup>2</sup>=99 %), all the studies were cross-sectional of convenience sampling, conducted in healthcare settings. The subgroup prevalence for the composite isolates was <strong>8.87 %</strong> (95 %CI: 2.72 – 17.77, I<sup>2</sup>=98.7), otherwise responsive isolates was <strong>11.37 %</strong> (95 %CI: 4.31 – 20.72, I<sup>2</sup>=98.3 %), otherwise resistant isolates was <strong>23.55 %</strong> (95 %CI: 10.12 – 40.14, I<sup>2</sup>=99.1). The otherwise resistant isolates stratified analyses revealed that ESBL prevalence was <strong>38.94 %</strong> (95 %CI: 21.63 – 57.79, I<sup>2</sup>=99.2 %), MDR was <strong>15.99 %</strong> (95 %CI: 2.46 – 37.00, I<sup>2</sup>=99 %), MRSA was <strong>52.37 %</strong> (95 %CI: 13.91 – 89.50, I2=88 %), Nosocomial infections prevalence was <strong>23.55 %</strong> (95 %CI: 10.12 – 40.14, I<sup>2</sup>=98.2 %). The ESKAPE bacterial strains accounted for the majority of resistance.</div></div><div><h3>Conclusion</h3><div>Qatar’s AMR overall prevalence is close to the global estimates, however the resistant isolates prevalence is higher than average according to the global estimates for high-income countries. The AMR public health response including national action plan to combat AMR and antimicrobial stewardship programs need to be orchestrated. AMR epidemiological research needs improvement in expanding coverage across diverse population groups to ensure greater clarity and precision in identifying bacterial infections and antibiotic classifications.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"18 6","pages":"Article 102732"},"PeriodicalIF":4.7000,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The epidemiology of antimicrobial resistant bacterial infection in Qatar: A systematic review and meta-analysis\",\"authors\":\"Rasha Abu El-Ruz , Ovelia A. Masoud , Amal A. Ibrahim , Tawanda Chivese , Susu M. Zughaier\",\"doi\":\"10.1016/j.jiph.2025.102732\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Antimicrobial resistance (AMR) is the current silent pandemic responsible for approximately five million deaths annually. According to the WHO, antimicrobial resistance is one of the top global public health threats and the third leading cause of death worldwide.</div></div><div><h3>Method</h3><div>This systematic review and meta-analyses aims to provide Qatar's first comprehensive epidemiological assessment of AMR. We conducted extensive search of three databases (PubMed, Embase and Web of Science) using broad search terms with no restrictions. The meta-analysis of prevalence was done using the Freeman-Turkey transformation and random effects models. Subgroup analysis was performed for three categories; the composite isolates, otherwise responsive isolates, and otherwise resistant isolates.</div></div><div><h3>Results</h3><div>The search yielded a total of 1258 publications, of which 55 publications were included. The overall prevalence of all isolates was <strong>13.64 %</strong> (95 %CI: 6.80 – 22.11, I<sup>2</sup>=99 %), all the studies were cross-sectional of convenience sampling, conducted in healthcare settings. The subgroup prevalence for the composite isolates was <strong>8.87 %</strong> (95 %CI: 2.72 – 17.77, I<sup>2</sup>=98.7), otherwise responsive isolates was <strong>11.37 %</strong> (95 %CI: 4.31 – 20.72, I<sup>2</sup>=98.3 %), otherwise resistant isolates was <strong>23.55 %</strong> (95 %CI: 10.12 – 40.14, I<sup>2</sup>=99.1). The otherwise resistant isolates stratified analyses revealed that ESBL prevalence was <strong>38.94 %</strong> (95 %CI: 21.63 – 57.79, I<sup>2</sup>=99.2 %), MDR was <strong>15.99 %</strong> (95 %CI: 2.46 – 37.00, I<sup>2</sup>=99 %), MRSA was <strong>52.37 %</strong> (95 %CI: 13.91 – 89.50, I2=88 %), Nosocomial infections prevalence was <strong>23.55 %</strong> (95 %CI: 10.12 – 40.14, I<sup>2</sup>=98.2 %). The ESKAPE bacterial strains accounted for the majority of resistance.</div></div><div><h3>Conclusion</h3><div>Qatar’s AMR overall prevalence is close to the global estimates, however the resistant isolates prevalence is higher than average according to the global estimates for high-income countries. The AMR public health response including national action plan to combat AMR and antimicrobial stewardship programs need to be orchestrated. AMR epidemiological research needs improvement in expanding coverage across diverse population groups to ensure greater clarity and precision in identifying bacterial infections and antibiotic classifications.</div></div>\",\"PeriodicalId\":16087,\"journal\":{\"name\":\"Journal of Infection and Public Health\",\"volume\":\"18 6\",\"pages\":\"Article 102732\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-03-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Public Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1876034125000814\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1876034125000814","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
The epidemiology of antimicrobial resistant bacterial infection in Qatar: A systematic review and meta-analysis
Background
Antimicrobial resistance (AMR) is the current silent pandemic responsible for approximately five million deaths annually. According to the WHO, antimicrobial resistance is one of the top global public health threats and the third leading cause of death worldwide.
Method
This systematic review and meta-analyses aims to provide Qatar's first comprehensive epidemiological assessment of AMR. We conducted extensive search of three databases (PubMed, Embase and Web of Science) using broad search terms with no restrictions. The meta-analysis of prevalence was done using the Freeman-Turkey transformation and random effects models. Subgroup analysis was performed for three categories; the composite isolates, otherwise responsive isolates, and otherwise resistant isolates.
Results
The search yielded a total of 1258 publications, of which 55 publications were included. The overall prevalence of all isolates was 13.64 % (95 %CI: 6.80 – 22.11, I2=99 %), all the studies were cross-sectional of convenience sampling, conducted in healthcare settings. The subgroup prevalence for the composite isolates was 8.87 % (95 %CI: 2.72 – 17.77, I2=98.7), otherwise responsive isolates was 11.37 % (95 %CI: 4.31 – 20.72, I2=98.3 %), otherwise resistant isolates was 23.55 % (95 %CI: 10.12 – 40.14, I2=99.1). The otherwise resistant isolates stratified analyses revealed that ESBL prevalence was 38.94 % (95 %CI: 21.63 – 57.79, I2=99.2 %), MDR was 15.99 % (95 %CI: 2.46 – 37.00, I2=99 %), MRSA was 52.37 % (95 %CI: 13.91 – 89.50, I2=88 %), Nosocomial infections prevalence was 23.55 % (95 %CI: 10.12 – 40.14, I2=98.2 %). The ESKAPE bacterial strains accounted for the majority of resistance.
Conclusion
Qatar’s AMR overall prevalence is close to the global estimates, however the resistant isolates prevalence is higher than average according to the global estimates for high-income countries. The AMR public health response including national action plan to combat AMR and antimicrobial stewardship programs need to be orchestrated. AMR epidemiological research needs improvement in expanding coverage across diverse population groups to ensure greater clarity and precision in identifying bacterial infections and antibiotic classifications.
期刊介绍:
The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.
The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.
It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.